LNC therapeutics leading biotech in the development of innovative microbiome-based therapies

LNC Therapeutics, a leading biotech in next-generation microbiome-based therapies that harness the power of keystone single-strain bacteria

more +
Our Story

Our team is committed to deliver therapeutic solutions to patients with high needs

more +
therapeutic solutions

LNC Therapeutics is the 1st company to harness the therapeutic potential of Christensenella

Our leadership

Georges RAWADI
Georges RAWADI

Passionate about innovation

A former researcher at the Institut Pasteur, Georges was Vice-President of Business Development & Intellectual Property and a member of the management team at Celyad.

Sandrine CLAUS
Sandrine CLAUS CSO
Sandrine CLAUS

Beyond the state of the art

Sandrine joined LNC Therapeutics in 2017 as Chief Scientific Officer and is also Associate Professor in Integrative Metabolism in the department of Food and Nutritional Sciences at the University of Reading.

Fabrice GUEZ
Fabrice GUEZ CFO
Fabrice GUEZ

Putting people first

An experienced CFO, Fabrice decided to switch gears after gaining extensive experience as a financial auditor, getting involved in operations at a number of pharmaceutical SMEs, where he successfully headed up change management processes.

Leveraging partnership for success more +
Quay Pharma
Cornel University
to meet us
4-6 February, 2020
Microbiome Drug Development Summit - Europe -
> more
10-11 March, 2020
Pharmabiotics 2020
> more
23-25 March, 2020
BioSpring Europe 2020
> more
11-12 May, 2020
BioEquity Europe 2020
> more
8-11 June, 2020
Bio International Convention 2020
> more
28-30 June, 2020
IHMC Congress 2020
> more
Microbiome & us
Sep 8, 2020
LNC Therapeutics Receives FDA Investigational New Drug Approval to Initiate a Phase 1 Clinical Trial on Xla1 for the...
> more
Apr 15, 2020
LNC Therapeutics announces the acquisition of an exclusive worldwide license on the first patent related to...
> more
Press / Media
Nov 12, 2019
Biotechs investments disrupt Big Pharma business model The pharmaceutical industry is in a state of flux, with...
> more
Sep 6, 2019
Chaque semaine, Maddyness dresse le bilan des levées de fonds de la semaine qui vient de s’écouler. Cette semaine,...
> more
Apr 22, 2020
Keystone gut bacteria are the foundation of the whole microbial ecosystem because they provide very specific metabolic...
> more
Dec 6, 2019
The term “microbiome” refers to the collection of microorganisms (or microbiota) – including bacteria, viruses and...
> more
now on twitter
LNC Therapeutics

The research aimed to determine whether a 28-day period of disrupted sleep changed the microbiota in rats… t.co/ikfBJmsJj3

LNC Therapeutics © 2020 - all rights reserved terms and conditions Influa | Web Agency © 2018